Table 2 BMI, weight, waist circumference, Fat and Percent Fat, serum glucose and HbA1c levels evolution during the follow-up across the two OSA groups.
Baseline | 6 Months | 12 Months | P* | P† | |
|---|---|---|---|---|---|
BMI, kg/m2 | |||||
No OSA (N = 25) | 44.6 ± 5.5 | 32.79 (30.02–35.56) | 29.19 (25.47–32.9) | < 0.001 | 0.58 |
OSA (N = 48) | 45.9 ± 6.7 | 35.13 (32.56–37.7) | 33.15 (29.85–36.45) | ||
P‡ | – | 0.24 | 0.128 | ||
Weight, kg | |||||
No OSA (N = 25) | 122.6 ± 18.7 | 89.38 (80.99–97.75) | 79.4 (69.42–89.38) | < 0.001 | 0.71 |
OSA (N = 48) | 128.9 ± 19.6 | 99.23 (91.81–106.66) | 93.7 (83.24–104.16) | ||
P‡ | 0.092 | 0.076 | |||
Waist circumference, cm | |||||
No OSA (N = 25) | 122.0 ± 11.9 | 97.87 (90.63–105.11) | 91.89 (82.96–100.82) | < 0.001 | 0.51 |
OSA (N = 48) | 129.9 ± 12.8 | 107.78 (102.03–113.53) | 105.47 (97.22–113.72) | ||
P‡ | – | 0.034 | 0.035 | ||
Fat, kg | |||||
No OSA (N = 25) | 54.9 (50.6–59.1) | 33.1 (29.9–36.3) | 27.5 (23.6–31.3) | < 0.001 | 0.45 |
OSA (N = 48) | 58.3 (55.3–61.3) | 34.9 (32.3–37.6) | 31.7 (28.7–34.7) | ||
P‡ | – | 0.38 | 0.09 | ||
Percent Fat, % | |||||
No OSA (N = 25) | 44.9 (42.8–47.2) | 35.4 (33.8–36.9) | 30.8 (28.8–32.7) | < 0.001 | 0.02 |
OSA (N = 48) | 45.3 (43.7–46.9) | 36.9 (35.6–38.3) | 34.8 (33.2–36.3) | ||
P‡ | – | 0.16 | 0.002 | ||
Serum glucose, mg/dL | |||||
No OSA (N = 25) | 96.0 (85.0–102.0) | 86.53 (82.62–90.44) | 88.6 (82.56–94.64) | < 0.001 | 0.19 |
OSA (N = 48) | 102.5 (93.5–122.5) | 90.5 (82.02–98.97) | 86.85 (82.15–91.55) | ||
P‡ | – | 0.5 | 0.64 | ||
HbA1c, % | |||||
No OSA (N = 25) | 5.3 (4.9–5.5) | 5.2 (5–5.3) | 5 (4.7–5.3) | < 0.001 | 0.4 |
OSA (N = 48) | 5.7 (5.3–6.0) | 5.4 (5.1–5.7) | 5.2 (5–5.3) | ||
P‡ | – | 0.335 | 0.172 | ||
